Schedule 13G ownership disclosure

IMPEL NEUROPHARMA INC

Security class unavailable · CUSIP: 45258K109

Event date: 2021-04-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,884,789
Percent of class
14.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-024907
Form type
SC 13G
Filer
IPI Legacy Liquidation Co
CIK
CIK 1445499
Filed
May 06, 2021
Reporting period
Apr 27, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub